SG11201703298SA - Activated bifidobacteria and methods of use thereof - Google Patents
Activated bifidobacteria and methods of use thereofInfo
- Publication number
- SG11201703298SA SG11201703298SA SG11201703298SA SG11201703298SA SG11201703298SA SG 11201703298S A SG11201703298S A SG 11201703298SA SG 11201703298S A SG11201703298S A SG 11201703298SA SG 11201703298S A SG11201703298S A SG 11201703298SA SG 11201703298S A SG11201703298S A SG 11201703298SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- activated bifidobacteria
- bifidobacteria
- activated
- Prior art date
Links
- 241000186000 Bifidobacterium Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462068553P | 2014-10-24 | 2014-10-24 | |
US201562133243P | 2015-03-13 | 2015-03-13 | |
PCT/US2015/057226 WO2016065324A1 (en) | 2014-10-24 | 2015-10-23 | Activated bifidobacteria and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201703298SA true SG11201703298SA (en) | 2017-05-30 |
Family
ID=55761664
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201703298SA SG11201703298SA (en) | 2014-10-24 | 2015-10-23 | Activated bifidobacteria and methods of use thereof |
SG10202002593SA SG10202002593SA (en) | 2014-10-24 | 2015-10-23 | Activated bifidobacteria and methods of use thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202002593SA SG10202002593SA (en) | 2014-10-24 | 2015-10-23 | Activated bifidobacteria and methods of use thereof |
Country Status (10)
Country | Link |
---|---|
US (2) | US10716816B2 (de) |
EP (1) | EP3209308B1 (de) |
CN (2) | CN114376234A (de) |
AU (2) | AU2015335601A1 (de) |
BR (1) | BR112017008284A8 (de) |
CA (1) | CA2965663C (de) |
DK (1) | DK3209308T3 (de) |
MX (1) | MX2017005260A (de) |
SG (2) | SG11201703298SA (de) |
WO (1) | WO2016065324A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
SG11201703298SA (en) | 2014-10-24 | 2017-05-30 | Evolve Biosystems Inc | Activated bifidobacteria and methods of use thereof |
GB2551642B (en) | 2014-10-31 | 2020-09-23 | Pendulum Therapeutics Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
EP3395351A1 (de) | 2014-12-23 | 2018-10-31 | 4D Pharma Research Limited | Immunmodulation |
JP6427278B2 (ja) | 2014-12-23 | 2018-11-21 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | pirinポリペプチド及び免疫モジュレーション |
CN107846957A (zh) * | 2015-03-05 | 2018-03-27 | 雀巢产品技术援助有限公司 | 用于改善婴儿或幼儿粪便稠度或频率的组合物 |
SG10202002010VA (en) * | 2015-03-13 | 2020-05-28 | Evolve Biosystems Inc | Compositions that metabolize or sequester free sugar monomers and uses thereof |
BR112017025005A2 (pt) | 2015-06-15 | 2018-08-07 | 4D Pharma Research Limited | composições compreendendo cepas baterianas |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
PT3650033T (pt) | 2015-06-15 | 2022-05-25 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
CN107847529B (zh) | 2015-06-15 | 2022-05-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41013A (fr) | 2015-11-20 | 2017-08-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
EA035949B1 (ru) | 2016-03-04 | 2020-09-04 | 4Д ФАРМА ПиЭлСи | Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности |
SG11201807809XA (en) * | 2016-03-11 | 2018-10-30 | Evolve Biosystems Inc | A transient commensal microorganism for improving gut health |
CA3029631A1 (en) * | 2016-07-01 | 2018-01-04 | Evolve Biosystems, Inc. | Method for facilitating maturation of the mammalian immune system |
TW201821093A (zh) | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
MA48939B1 (fr) | 2017-05-22 | 2021-06-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
LT3638271T (lt) | 2017-06-14 | 2021-01-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterines padermes |
HUE053488T2 (hu) | 2017-06-14 | 2021-06-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
MD3600364T2 (ro) | 2017-06-14 | 2020-12-31 | 4D Pharma Res Ltd | Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora |
CN107365705B (zh) * | 2017-07-14 | 2021-01-12 | 江苏微康生物科技有限公司 | 一种油溶性益生菌冻干菌粉的冻干保护剂及其应用 |
AU2018326705A1 (en) | 2017-08-30 | 2020-03-05 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
SG11202002325VA (en) * | 2017-09-13 | 2020-04-29 | Evolve Biosystems Inc | Metabolomic revision of mammalian infants |
US20200345055A1 (en) | 2018-01-17 | 2020-11-05 | Evolve Biosystems, Inc. | Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains |
SG11202011820VA (en) * | 2018-05-30 | 2020-12-30 | Evolve Biosystems Inc | Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis |
SG11202011817WA (en) * | 2018-06-01 | 2020-12-30 | Evolve Biosystems Inc | Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires |
US20210161924A1 (en) * | 2018-06-19 | 2021-06-03 | Evolve Biosystems, Inc. | Novel oligosaccharides for use in prebiotic applications |
CA3130834A1 (en) | 2019-02-22 | 2020-08-27 | Aquero Canada Ltd. | Fortified milk compositions and their processes of preparation |
JP2023519115A (ja) * | 2020-03-20 | 2023-05-10 | グリコム・アクティーゼルスカブ | 固形のhmo製品を提供するための方法及びそれにより得られる固形のhmo製品 |
CN111826324A (zh) * | 2020-08-05 | 2020-10-27 | 厦门惠盈动物科技有限公司 | 一种鼠李糖乳杆菌菌粉的制备方法 |
CN114568520A (zh) * | 2020-11-30 | 2022-06-03 | 内蒙古伊利实业集团股份有限公司 | 包含长双歧杆菌婴儿亚种的婴幼儿配方粉及其应用 |
CN114568516A (zh) * | 2020-11-30 | 2022-06-03 | 内蒙古伊利实业集团股份有限公司 | 包含长双歧杆菌婴儿亚种与母乳低聚糖的组合物及其应用 |
EP4258901A1 (de) | 2020-12-11 | 2023-10-18 | DSM IP Assets B.V. | Verbesserte präbiotische formulierungen |
IT202100024911A1 (it) * | 2021-09-29 | 2023-03-29 | Univ Degli Studi Di Napoli Federico Ii Dipartimento Di Fisica Ettore Pancini | Prebiotico a base di "scotta" delattosata per la prevenzione e gestione della disbiosi intestinale |
CN116407484A (zh) * | 2021-12-29 | 2023-07-11 | 嘉必优生物技术(武汉)股份有限公司 | 一种修护皮肤屏障的护肤组合物及其应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716615A (en) | 1992-02-10 | 1998-02-10 | Renata Maria Anna Cavaliere Vesely | Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
RU2180915C1 (ru) | 2001-04-28 | 2002-03-27 | Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского | Консорциум бифидобактерий и лактобацилл, используемый для приготовления бактериальных препаратов, заквасок для кисломолочных продуктов, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, предназначенных для коррекции микрофлоры детей в возрасте до 3-х лет |
RU2373769C2 (ru) * | 2003-10-24 | 2009-11-27 | Н.В. Нютрисиа | Синбиотическая композиция для детей |
US20070082087A1 (en) * | 2005-10-06 | 2007-04-12 | Schweitzer Biotech Company Ltd. | Fermented milk products containing bifidobacterium longum and isomalto oligosaccharide and the process for producing the same |
EP1776877A1 (de) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Methode zur Förderung der Darmflora |
WO2007140622A1 (en) | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Dairy-derived probiotic compositions and uses thereof |
WO2008033520A2 (en) | 2006-09-15 | 2008-03-20 | The Regents Of The University Of California | Bifidobacterial gene sequences and their use |
US8197872B2 (en) | 2007-05-17 | 2012-06-12 | The Regents Of The University Of California | Human milk oligosaccharides to promote growth of beneficial gut bacteria |
WO2008153377A1 (en) * | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
EP2072052A1 (de) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Verhinderung opportunistischer Infektionen bei Personen mit schwachem Immunsystem |
UA32462U (uk) | 2008-02-14 | 2008-05-12 | Харьковский Национальный Медицинский Университет | Спосіб оцінки ефективності корекції порушень мікробіоценозу кишечнику у дітей молодшого віку з атопічним дерматитом |
CA2658440C (en) * | 2008-04-04 | 2016-08-23 | Kraft Foods Global Brands Llc | Dairy composition with probiotics and anti-microbial system |
WO2009144137A1 (en) * | 2008-05-27 | 2009-12-03 | Nestec S.A. | Probiotics to improve gut microbiota |
EP2143341A1 (de) | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nährstoffzusammensetzung mit Oligosaccharid-Mischung |
MX349705B (es) * | 2008-11-11 | 2017-08-09 | Alimentary Health Ltd | Bifidobacterium longum. |
EP2370084B1 (de) | 2008-12-02 | 2014-10-22 | Prolacta Bioscience, Inc. | Muttermilchpermeatzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung |
US9649380B2 (en) | 2009-01-12 | 2017-05-16 | Pfizer Italia S.R.L. | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
US8198872B2 (en) | 2009-03-10 | 2012-06-12 | Honeywell International, Inc. | Starter-generator with improved excitation |
US7888062B1 (en) * | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
MX2012009306A (es) | 2010-02-19 | 2012-09-12 | Glycom As | Produccion de 6'-o-sialil-lactosa y compuestos intermedios. |
WO2012009315A2 (en) | 2010-07-12 | 2012-01-19 | The Regents Of The University Of California | Bovine milk oligosaccharides |
EP2454948A1 (de) * | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung |
EP2465509A1 (de) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharid Zusammensetzung zur Behandlung von akuten Atemwegsinfektionen |
EP2465507A1 (de) * | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharid Zusammensetzung zur Behandlung von Hautkrankheiten |
EP2658402A1 (de) * | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Symbiotische zusammensetzung probiotischer und menschlicher milcholigosaccharide zur anregung des wachstums von günstiger darmflora |
US20140371173A1 (en) * | 2011-02-10 | 2014-12-18 | Nestec S.A. | Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk |
US9579353B2 (en) | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
DK2814835T3 (da) * | 2012-02-14 | 2019-06-11 | Univ California | Enzymer og fremgangsmåder til spaltning af N-glycaner fra glycoproteiner |
US10165788B2 (en) | 2013-06-17 | 2019-01-01 | The Regents Of The University Of California | Methods and compositions for improved digestion of milk oligosaccharides |
SG11201703298SA (en) | 2014-10-24 | 2017-05-30 | Evolve Biosystems Inc | Activated bifidobacteria and methods of use thereof |
WO2016094836A1 (en) | 2014-12-12 | 2016-06-16 | The Regents Of The University Of California | Reduction of milk glycans and their degradation products in the neonate gut |
-
2015
- 2015-10-23 SG SG11201703298SA patent/SG11201703298SA/en unknown
- 2015-10-23 CA CA2965663A patent/CA2965663C/en active Active
- 2015-10-23 WO PCT/US2015/057226 patent/WO2016065324A1/en active Application Filing
- 2015-10-23 DK DK15853612.8T patent/DK3209308T3/da active
- 2015-10-23 US US15/521,502 patent/US10716816B2/en active Active
- 2015-10-23 AU AU2015335601A patent/AU2015335601A1/en not_active Abandoned
- 2015-10-23 SG SG10202002593SA patent/SG10202002593SA/en unknown
- 2015-10-23 BR BR112017008284A patent/BR112017008284A8/pt not_active Application Discontinuation
- 2015-10-23 EP EP15853612.8A patent/EP3209308B1/de active Active
- 2015-10-23 MX MX2017005260A patent/MX2017005260A/es unknown
- 2015-10-23 CN CN202111546347.2A patent/CN114376234A/zh active Pending
- 2015-10-23 CN CN201580071135.XA patent/CN107249611A/zh active Pending
-
2020
- 2020-06-08 US US16/895,641 patent/US20200397837A1/en active Pending
-
2021
- 2021-07-09 AU AU2021204822A patent/AU2021204822A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10716816B2 (en) | 2020-07-21 |
BR112017008284A8 (pt) | 2023-04-11 |
DK3209308T3 (da) | 2022-10-03 |
WO2016065324A1 (en) | 2016-04-28 |
CN114376234A (zh) | 2022-04-22 |
EP3209308A4 (de) | 2018-06-27 |
US20170304375A1 (en) | 2017-10-26 |
AU2021204822A1 (en) | 2021-08-05 |
CA2965663A1 (en) | 2016-04-28 |
SG10202002593SA (en) | 2020-05-28 |
MX2017005260A (es) | 2018-01-30 |
EP3209308A1 (de) | 2017-08-30 |
EP3209308B1 (de) | 2022-08-03 |
CA2965663C (en) | 2023-04-04 |
AU2015335601A1 (en) | 2017-06-01 |
CN107249611A (zh) | 2017-10-13 |
BR112017008284A2 (pt) | 2017-12-19 |
US20200397837A1 (en) | 2020-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10202002593SA (en) | Activated bifidobacteria and methods of use thereof | |
IL250415B (en) | Antibodies against pd-l and methods of using them | |
HRP20210526T8 (hr) | Oksisteroli i postupci za njihovu uporabu | |
HK1255500A1 (zh) | 氧固醇及其使用方法 | |
PL3160498T3 (pl) | Cząsteczki na bazie IL-15 i sposoby ich zastosowania | |
GB201421847D0 (en) | Dispensers and methods of use thereof | |
IL256531B (en) | Oxysterols and methods of using them | |
IL251988A0 (en) | Compounds acting on glycans and methods of using them | |
GB201502084D0 (en) | Catheter devices and related methods | |
IL253234A0 (en) | Methods for transdifferentiation and methods to use them | |
EP3157528A4 (de) | Oxysterole und verfahren zur verwendung davon | |
GB201417048D0 (en) | Occupancy-control device and methods of use | |
GB201404470D0 (en) | Therapeutic methods and materials | |
SI3089971T1 (sl) | Spojine in postopki za uporabo | |
SG11201704473WA (en) | New methods and uses | |
EP3152281A4 (de) | Entschäumer und zugehöriges verfahren zur verwendung | |
ZA201703398B (en) | Pharmaceutical composition and methods | |
HK1256368A1 (zh) | 加利車黴素-抗體-藥物綴合物和使用方法 | |
HK1243077A1 (zh) | 呱啶基吡唑並嘧啶酮及其用途 | |
SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
ZA201606450B (en) | Compounds and their methods of use | |
IL248554A0 (en) | dr3 variants and their use | |
GB2558547B (en) | Actuatable paddle and methods of use | |
GB201509977D0 (en) | Dispensers and methods of use thereof | |
GB201403697D0 (en) | Compounds and methods of use |